Open Access

Modern Glycaemic Management to reduce CV risk in Diabetes

Event: ESC Congress 2021 - The Digital Experience
Topic: Cardiovascular Disease in Special Populations
Session type: Satellite Symposium
Sponsored by Abbott Diabetes Care
Date: 30 August 2021
Time: 09:00 - 09:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Introduction.

Speaker: Professor N. Marx (Aachen, DE)
Thumbnail

Adverse glycaemic measures in cardiac patients: HbA1c fails to provide the full picture.

Speaker: Doctor R. Ajjan (Leeds, GB)
Thumbnail

Is continuous glucose monitoring the solution?

Speaker: Associate Professor G. Lanza (Rome, IT)
Thumbnail

Live Questions & Answers.

Thumbnail

3 speakers from this session

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
28 presentations
0 follower

Doctor Ramzi Ajjan

, Leeds (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Associate Professor Gaetano A Lanza

Catholic University of the Sacred Heart, Rome (Italy)
1 presentation
0 follower

Related content

ESC Premium Access

Update on endocarditis in 2021

3 December 2021

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk